Transforming growth factor-beta 1 pathways in inflammatory airway diseases

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 6, 2014, Pages 699-707

  Yang, Y ^a   Zhang, N ^b,c   Lan, F ^b,c   Van Crombruggen, K ^b,c   Fang, L ^a   Hu, G ^a   Hong, S ^a   Bachert, C ^b,c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b GHENT UNIVERSITY   (Belgium)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

airway diseases; influencing factors; oxidative stress; smoking; transforming growth factor beta

Indexed keywords

ARACHIDONIC ACID; BRADYKININ; LEUKOTRIENE; MICRORNA; PROSTAGLANDIN; TRANSFORMING GROWTH FACTOR BETA1;

EXPERIMENTAL THERAPY; HUMAN; INFLAMMATORY AIRWAY DISEASE; INFLAMMATORY DISEASE; LOWER RESPIRATORY TRACT; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; REVIEW; SMOKING; UPPER RESPIRATORY TRACT; ANIMAL; DRUG EFFECTS; GENETICS; INFLAMMATION; METABOLISM; RESPIRATORY TRACT DISEASES; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACID; HUMANS; INFLAMMATION; METABOLIC NETWORKS AND PATHWAYS; MICRORNAS; RESPIRATORY TRACT DISEASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84899933256     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12403     Document Type: Review

References (87)

1. Piek E, Heldin CH, Ten Dijke P,. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999; 13: 2105-2124.
2. Konigshoff M, Kneidinger N, Eickelberg O,. TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen. Swiss Med Wkly 2009; 139: 554-563.
3. Huber S, Schramm C, Lehr HA, Mann A, Schmitt S, Becker C, et al. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4 + CD25 + T cells. J Immunol 2004; 173: 6526-6531.
4. Van Bruaene N, Perez-Novo CA, Basinski TM, Van Zele T, Holtappels G, De Ruyck N, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008; 121: 1435-1441.
5. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693-699.
6. Sejima T, Holtappels G, Bachert C,. The expression of fibrinolytic components in chronic paranasal sinus disease. Am J Rhinol Allergy 2011; 25: 1-6.
7. Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q,. Role of transforming growth factor-beta in airway remodeling in asthma. Am J Respir Cell Mol Biol 2011; 44: 127-133.
8. Van Bruaene N, Bachert C,. Tissue remodeling in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 2011; 11: 8-11.
9. Bachert C, Van Bruaene N, Toskala E, Zhang N, Olze H, Scadding G, et al. Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis-a GALEN study. Allergy 2009; 64: 520-533.
10. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61: 1280-1289.
11. Le Bellego F, Perera H, Plante S, Chakir J, Hamid Q, Ludwig MS,. Mechanical strain increases cytokine and chemokine production in bronchial fibroblasts from asthmatic patients. Allergy 2009; 64: 32-39.
12. Kim ES, Kim SH, Kim KW, Park JW, Kim YS, Sohn MH, et al. Basement membrane thickening and clinical features of children with asthma. Allergy 2007; 62: 635-640.
13. Hogg JC,. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-721.
14. Yang YC, Zhang N, Van Crombruggen K, Hu GH, Hong SL, Bachert C,. Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy 2012; 67: 1193-1202.
15. Semlali A, Jacques E, Rouabhia M, Milot J, Laviolette M, Chakir J,. Regulation of epithelial cell proliferation by bronchial fibroblasts obtained from mild asthmatic subjects. Allergy 2010; 65: 1438-1445.
16. Shi LL, Xiong P, Zhang L, Cao PP, Liao B, Lu X, et al. Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns. Allergy 2013; 68: 101-109.
17. Salib RJ, Howarth PH,. Transforming growth factor-beta in allergic inflammatory disease of the upper airways: friend or foe? Clin Exp Allergy 2009; 39: 1128-1135.
18. Dut R, Dizdar EA, Birben E, Sackesen C, Soyer OU, Besler T, et al. Oxidative stress and its determinants in the airways of children with asthma. Allergy 2008; 63: 1605-1609.
19. Noguchi C, Umino T, Miyazaki Y, Jinta T, Usui Y, Yoshizawa Y,. TGF-beta and glutathione promote tissue repair in cigarette smoke induced injury. J Med Dent Sci 2007; 54: 109-116.
20. Jeanson L, Kelly M, Coste A, Guerrera IC, Fritsch J, Nguyen-Khoa T, et al. Oxidative stress induces unfolding protein response and inflammation in nasal polyposis. Allergy 2012; 67: 403-412.
21. Chung KF, Marwick JA,. Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci 2010; 1203: 85-91.
22. Adcock IM, Caramori G, Barnes PJ,. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration 2011; 81: 265-284.
23. Pietinalho A, Pelkonen A, Rytila P,. Linkage between smoking and asthma. Allergy 2009; 64: 1722-1727.
24. Qi S, den Hartog GJ, Bast A,. Superoxide radicals increase transforming growth factor-beta1 and collagen release from human lung fibroblasts via cellular influx through chloride channels. Toxicol Appl Pharmacol 2009; 237: 111-118.
25. Koli K, Myllarniemi M, Keski-Oja J, Kinnula VL,. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 2008; 10: 333-342.
26. Moon JH, Kim TH, Lee HM, Lee SH, Choe W, Kim HK, et al. Overexpression of the superoxide anion and NADPH oxidase isoforms 1 and 4 (NOX1 and NOX4) in allergic nasal mucosa. Am J Rhinol Allergy 2009; 23: 370-376.
27. Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, et al. Chronic rhinosinusitis in Europe-an underestimated disease. A GA(2)LEN study. Allergy 2011; 66: 1216-1223.
28. Huvenne W, Perez-Novo CA, Derycke L, De Ruyck N, Krysko O, Maes T, et al. Different regulation of cigarette smoke induced inflammation in upper versus lower airways. Respir Res 2010; 11: 100.
29. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001; 163: 1476-1483.
30. Springer J, Scholz FR, Peiser C, Groneberg DA, Fischer A,. SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke. Biol Chem 2004; 385: 649-653.
31. Wang RD, Wright JL, Churg A,. Transforming growth factor-beta1 drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 2005; 33: 387-393.
32. Chuang CY, Chang CH, Huang YL,. Thioredoxin mediates remodeling factors of human bronchial epithelial cells upon interaction with house dust mite-stimulated eosinophils. Inhal Toxicol 2009; 21: 153-167.
33. Min MG, Song DJ, Miller M, Cho JY, McElwain S, Ferguson P, et al. Coexposure to environmental tobacco smoke increases levels of allergen-induced airway remodeling in mice. J Immunol 2007; 178: 5321-5328.
34. Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 490-495.
35. Mabalirajan U, Aich J, Leishangthem GD, Sharma SK, Dinda AK, Ghosh B,. Effects of vitamin E on mitochondrial dysfunction and asthma features in an experimental allergic murine model. J Appl Physiol 2009; 107: 1285-1292.
36. Mabalirajan U, Dinda AK, Sharma SK, Ghosh B,. Esculetin restores mitochondrial dysfunction and reduces allergic asthma features in experimental murine model. J Immunol 2009; 183: 2059-2067.
37. Mabalirajan U, Ahmad T, Leishangthem GD, Joseph DA, Dinda AK, Agrawal A, et al. Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. J Allergy Clin Immunol 2010; 125: 626-635.
38. Jin C, Zhou D, Lv F,. Beneficial effects of early (but not late) intervention of heme oxygenase-1 on bleomycin-induced pulmonary fibrosis in mice. Respir Physiol Neurobiol 2011; 175: 239-246.
39. Reddy SP,. The antioxidant response element and oxidative stress modifiers in airway diseases. Curr Mol Med 2008; 8: 376-383.
40. Ortiz JL, Milara J, Lluch J, De Diego A, Sanz C, Cortijo J,. Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress. Allergy 2013; 68: 64-73.
41. Calabrese C, Triggiani M, Marone G, Mazzarella G,. Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma. Allergy 2000; 55 (Suppl 61): 27-30.
42. Perez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C,. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005; 115: 1189-1196.
43. Patou J, Holtappels G, Affleck K, Gevaert P, Perez-Novo C, Van Cauwenberge P, et al. Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue. J Inflamm (Lond) 2009; 6: 11.
44. Patou J, Gevaert P, Van Zele T, Holtappels G, van Cauwenberge P, Bachert C,. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008; 121: 110-115.
45. Pezato R, Swierczynska-Krepa M, Nizankowska-Mogilnicka E, Derycke L, Bachert C, Perez-Novo CA,. Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis. Allergy 2012; 67: 1347-1356.
46. Prado CM, Yano L, Rocha G, Starling CM, Capelozzi VL, Leick-Maldonado EA, et al. Effects of inducible nitric oxide synthase inhibition in bronchial vascular remodeling-induced by chronic allergic pulmonary inflammation. Exp Lung Res 2011; 37: 259-268.
47. Barbarin V, Arras M, Misson P, Delos M, McGarry B, Phan SH, et al. Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice. Am J Respir Cell Mol Biol 2004; 31: 78-85.
48. Kolodsick JE, Peters-Golden M, Larios J, Toews GB, Thannickal VJ, Moore BB,. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol 2003; 29: 537-544.
49. Togo S, Liu X, Wang X, Sugiura H, Kamio K, Kawasaki S, et al. PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts. Am J Physiol Lung Cell Mol Physiol 2009; 296: L959-L969.
50. Selige J, Hatzelmann A, Dunkern T,. The differential impact of PDE4 subtypes in human lung fibroblasts on cytokine-induced proliferation and myofibroblast conversion. J Cell Physiol 2011; 226: 1970-1980.
51. Bosse Y, Thompson C, McMahon S, Dubois CM, Stankova J, Rola-Pleszczynski M,. Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation. Clin Exp Allergy 2008; 38: 113-121.
52. Lee KS, Kim SR, Park HS, Park SJ, Min KH, Lee KY, et al. Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice. J Allergy Clin Immunol 2007; 119: 141-149.
53. Shimbori C, Shiota N, Okunishi H,. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Eur J Pharmacol 2011; 650: 424-430.
54. Izumo T, Kondo M, Nagai A,. Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis. Eur Respir J 2009; 34: 1444-1451.
55. Shim YM, Zhu Z, Zheng T, Lee CG, Homer RJ, Ma B, et al. Role of 5-lipoxygenase in IL-13-induced pulmonary inflammation and remodeling. J Immunol 2006; 177: 1918-1924.
56. Riddick CA, Serio KJ, Hodulik CR, Ring WL, Regan MS, Bigby TD,. TGF-beta increases leukotriene C4 synthase expression in the monocyte-like cell line, THP-1. J Immunol 1999; 162: 1101-1107.
57. Perng DW, Wu YC, Chang KT, Wu MT, Chiou YC, Su KC, et al. Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathway. Am J Respir Cell Mol Biol 2006; 34: 101-107.
58. Austin CE, Foreman JC,. A study of the action of bradykinin and bradykinin analogues in the human nasal airway. J Physiol 1994; 478: 351-356.
59. Shirasaki H, Kanaizumi E, Himi T,. Immunohistochemical localization of the bradykinin B1 and B2 receptors in human nasal mucosa. Mediators Inflamm 2009; 2009: 102406.
60. Rostkowska-Nadolska B, Kapral M, Fraczek M, Kowalczyk M, Gawron W, Mazurek U,. Transcriptional activity of genes-encoding kinin B1 and B2 receptors and kinin-dependent genes in nasal polyps. Adv Med Sci 2009; 54: 211-220.
61. Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N, et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124: 253-259.
62. Bertram CM, Misso NL, Fogel-Petrovic M, Figueroa CD, Foster PS, Thompson PJ, et al. Expression of kinin receptors on eosinophils: comparison of asthmatic patients and healthy subjects. J Leukoc Biol 2009; 85: 544-552.
63. Kim JH, Jain D, Tliba O, Yang B, Jester WF Jr, Panettieri RA Jr, et al. TGF-beta potentiates airway smooth muscle responsiveness to bradykinin. Am J Physiol Lung Cell Mol Physiol 2005; 289: L511-L520.
64. Vancheri C, Gili E, Failla M, Mastruzzo C, Salinaro ET, Lofurno D, et al. Bradykinin differentiates human lung fibroblasts to a myofibroblast phenotype via the B2 receptor. J Allergy Clin Immunol 2005; 116: 1242-1248.
65. Vasquez-Pinto LM, Nantel F, Sirois P, Jancar S,. Bradykinin B(1) receptor antagonist R954 inhibits eosinophil activation/proliferation/migration and increases TGF-beta and VEGF in a murine model of asthma. Neuropeptides 2010; 44: 107-113.
66. Mabalirajan U, Aich J, Agrawal A, Ghosh B,. Mepacrine inhibits subepithelial fibrosis by reducing the expression of arginase and TGF-beta1 in an extended subacute mouse model of allergic asthma. Am J Physiol Lung Cell Mol Physiol 2009; 297: L411-L419.
67. Rose CE Jr, Sung SS, Fu SM,. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 2003; 10: 273-288.
68. Bitencourt CS, Pereira PA, Ramos SG, Sampaio SV, Arantes EC, Aronoff DM, et al. Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis. Fibrogenesis Tissue Repair 2011; 4: 3.
69. Qin XJ, Zhang GS, Zhang X, Qiu ZW, Wang PL, Li YW, et al. Protein tyrosine phosphatase SHP2 regulates TGF-beta1 production in airway epithelia and asthmatic airway remodeling in mice. Allergy 2012; 67: 1547-1556.
70. Zheng J, Jiang HY, Li J, Tang HC, Zhang XM, Wang XR, et al. MicroRNA-23b promotes tolerogenic properties of dendritic cells in vitro through inhibiting Notch1/NF-κB signalling pathways. Allergy 2012; 67: 362-370.
71. Butz H, Racz K, Hunyady L, Patocs A,. Crosstalk between TGF-beta signaling and the microRNA machinery. Trends Pharmacol Sci 2012; 33: 382-393.
72. Martin J, Jenkins RH, Bennagi R, Krupa A, Phillips AO, Bowen T, et al. Post-transcriptional regulation of Transforming Growth Factor Beta-1 by microRNA-744. PLoS ONE 2011; 6: e25044.
73. Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, et al. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 2010; 31: 1561-1566.
74. Bowen T, Jenkins RH, Fraser DJ,. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. J Pathol 2013; 229: 274-285.
75. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010; 207: 1589-1597.
76. Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, Yu G, et al. Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol 2012; 47: 879-887.
77. Pottier N, Maurin T, Chevalier B, Puissegur MP, Lebrigand K, Robbe-Sermesant K, et al. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial- mesenchymal interactions. PLoS ONE 2009; 4: e6718.
78. Yang S, Banerjee S, de Freitas A, Sanders YY, Ding Q, Matalon S, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol 2012; 180: 484-493.
79. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 2011; 45: 287-294.
80. Yang S, Xie N, Cui H, Banerjee S, Abraham E, Thannickal VJ, et al. miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis. FASEB J 2012; 26: 3790-3799.
81. Lu TX, Rothenberg ME,. Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. J Allergy Clin Immunol 2013; 132: 3-13.
82. Suojalehto H, Toskala E, Kilpeläinen M, Majuri ML, Mitts C, Lindström I, et al. MicroRNA profiles in nasal mucosa of patients with allergic and nonallergic rhinitis and asthma. Int Forum Allergy Rhinol 2013; 3: 612-620.
83. Zhang XH, Zhang YN, Li HB, Hu CY, Wang N, Cao PP, et al. Overexpression of miR-125b, a novel regulator of innate immunity, in eosinophilic chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med 2012; 185: 140-151.
84. Wang SL, Yao HH, Guo LL, Dong L, Li SG, Gu YP, et al. Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA. Cancer Genet Cytogenet 2009; 190: 8-14.
85. Santibanez JF, Quintanilla M, Bernabeu C,. TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2011; 121: 233-251.
86. Akhurst RJ, Hata A,. Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov 2012; 11: 790-811.
87. Mayer AK, Bartz H, Fey F, Schmidt LM, Dalpke AH,. Airway epithelial cells modify immune responses by inducing an anti-inflammatory microenvironment. Eur J Immunol 2008; 38: 1689-1699.